To reduce cancer incidence, morbidity and mortality through multifaceted cancer prevention approaches on the local, national and international levels.

To create and expand the highest standard of excellence in cancer prevention programs of clinical care, education and translational research.

• Expand the clinical application of basic science, translational, epidemiological and behavioral science research

• Promote and maintain multidisciplinary approaches, including the integration of personnel and resources of clinical and laboratory programs. Develop and enhance collaborations with other departments both within and outside the division (i.e., chemoprevention)

• Continue evaluation of ongoing molecular diagnostic activities related to genetic testing and facilitate strategic decision making regarding the services to offer at M. D. Anderson

• Continue developing clinically relevant preclinical chemoprevention models through the prevention lab (e.g., tissue/organ gene knockout models)

• Complete faculty recruitment for the medical director position in Clinical Cancer Genetics and for an assistant/associate professor in clinical research

• Consolidate and expand current research programs in the areas of GI, GU, skin, breast and esophageal carcinogenesis

• Maintain leadership in accrual to the Study of Tamoxifen and Raloxifene (STAR)

• Implement the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

• Continue to strengthen and expand collaborations with the Department of Carcinogenesis at Science Park and the Center for Research on Environmental Diseases

• Significantly expand the overall laboratory program in terms of space and resources